Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19 (Ventanyl Trial)

NCT05165992 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT05165992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05165992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19 (Ventanyl Trial)
Lead sponsor
Hamad Medical Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2022
Completion date
December 31, 2022
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia